FIELD: biotechnology.
SUBSTANCE: present invention relates to multidomain vesicle, and can be used in medicine. According to the present invention, the multidomain vesicle comprises: at least two liposomes in contact and connected to each other, and an outer wall of the multi-domain vesicle surrounding said liposomes. Multi-domain vesicle is formed from an oil phase and an aqueous phase and can encapsulate immunostimulating materials in both phases.
EFFECT: in comparison with existing liposomes, the multidomain vesicle of the present invention has a higher efficacy of loading active agents and higher stability in vivo.
9 cl, 44 dwg, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| MULTIDOMAIN VESICLE COMPRISING A MATERIAL WHICH CONTROLS AN IMMUNOSUPPRESSIVE FACTOR, A METHOD FOR PRODUCTION THEREOF AND AN IMMUNOMODULATING COMPOSITION THEREOF | 2018 |
|
RU2733124C1 |
| COMPOSITION OF LIPID VESICLES AND METHODS OF APPLICATION | 2011 |
|
RU2595872C2 |
| TOLL-LIKE RECEPTOR 7 OR 8 AGONIST AND CHOLESTEROL COMPLEX AND ITS USE | 2020 |
|
RU2790702C1 |
| PEGYLATED LIPOSOMES AND THEIR APPLICATION METHODS | 2017 |
|
RU2796539C2 |
| PYRIMIDINE COMPOUND | 2016 |
|
RU2759917C2 |
| PHARMACEUTICAL COMPOSITION BASED ON PLGA FOR THE INDUCTION OF THE EFFECTIVE MUCOSAL IMMUNE RESPONSE | 2018 |
|
RU2742580C2 |
| IMMUNOSTIMULATING OLIGONUCLEOTIDES | 2009 |
|
RU2477753C2 |
| EHRLICHIA VACCINES AND IMMUNOGENIC COMPOSITIONS | 2020 |
|
RU2824881C2 |
| IMMUNOSTIMULATORY OLIGONUCLEOTIDES | 2012 |
|
RU2610690C2 |
| COMPOSITION, STIMULATING IMMUNE RESPONSE, WHICH CONTAINS NANOPARTICLES BASED ON COPOLYMER OF METHYLVINYL ETHER OF MALEIC ANHYDRIDE | 2005 |
|
RU2379028C2 |
